Which statement describes an aspect of all Phase II clinical trials? Which statement describes an aspect of all Phase II clinical trials?
A. randomized controlled multicenter trials on large patient groups
B. designed to assess the pharmacovigilance, pharmacokinetics, and pharmacodynamics of a drug
C. in vitro and in vivo experiments using wide-ranging doses of the drug
D. designed to assess how well the drug works and further assess safety
Answer: D